|
2024
|
Invention
|
Anti-il-31ra antibody-containing formulations.
In one non-limiting embodiment, the present discl... |
|
|
Invention
|
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use.
The d... |
|
|
Invention
|
Modified aminoacyl-trna synthetase and use thereof.
The present invention provides modified arni... |
|
|
Invention
|
Antibody substituting for function of blood coagulation factor viii.
The present inventors produ... |
|
|
Invention
|
Cell injury inducing therapeutic drug for use in cancer therapy.
The present invention provides ... |
|
|
Invention
|
Method of modifying isoelectric point of antibody via amino acid substitution in cdr.
The presen... |
|
|
Invention
|
Cyclic compound having selective kras inhibitory effect on hras and nras.
Cyclic compounds that ... |
|
|
Invention
|
Composition for treating il-6-related diseases.
The present invention provides a pharmaceutical ... |
|
|
Invention
|
High concentration antibody-containing liquid formulation.
The problem to be solved is to provid... |
|
|
Invention
|
Information processing system, information processing method, program, and method for manufacturi... |
|
|
Invention
|
Medicine container, medicine suction method, medicine discharge method, and gasket release tool. ... |
|
|
Invention
|
Method for preparing aromatic amino acid derivative.
The present invention provides methods of e... |
|
|
Invention
|
Medicine for treating or preventing cancer. Provided is a medicine for treating or preventing can... |
|
|
Invention
|
Cyclic peptide compound having kras inhibitory action.
The present inventors found cyclic peptid... |
|
|
Invention
|
Compositions comprising antigen-binding molecules.
The present invention relates to pharmaceutic... |
|
|
Invention
|
Method for treating and/or preventing regnase-1-related disease.
The present invention found tha... |
|
|
Invention
|
Polypeptide modification method for purifying polypeptide multimers.
The present invention provi... |
|
|
Invention
|
Crystal of nitrogen-containing heterocyclic compound having nrf2 activation effect. The present i... |
|
|
Invention
|
Multi-specific antigen-binding molecule having alternative function to function of blood coagulat... |
|
|
Invention
|
Pharmaceutical composition for use in prevention and/or treatment of disease that develops or pro... |
|
|
Invention
|
Polypeptide including antigen-binding domain and carrying section.
The present invention relates... |
|
|
Invention
|
Methods and compositions for treating cancer. The invention provides methods and compositions for... |
|
|
Invention
|
Treatment of thyroid eye disease with satralizumab. All currently available treatment options for... |
|
|
Invention
|
Method for producing amide group-containing compound using n-carboxyamino acid anhydride. This me... |
|
|
Invention
|
Method for producing cyclic peptide compound. As a method for cyclization when producing a cyclic... |
|
|
Invention
|
Composition containing cyclic peptide compound and surfactant. 1123456101011163978888999911166 al... |
|
|
Invention
|
Method for stabilizing protein-containing pharmaceutical preparation. The present invention provi... |
|
|
Invention
|
Method for screening molecules of interest capable of forming complexes with plurality of types o... |
|
|
Invention
|
Biomarker for predicting prognosis in sepsis patient and use thereof. The present invention provi... |
|
|
Invention
|
Anti-latent tgf-beta 1 antibodies and methods of use.
An objective of the invention is to provid... |
|
|
G/S
|
Pharmaceutical preparations. Providing education and training services in the medical
field. Pro... |
|
2023
|
Invention
|
Cross-species anti-latent tgf-beta 1 antibodies and methods of use.
The present invention provid... |
|
|
Invention
|
Method for screening for molecules of interest capable of forming complexes with plurality of tar... |
|
|
Invention
|
Cell culture plan creation device and cell culture system. In a cell culture plan creation device... |
|
|
Invention
|
Method for screening molecules of interest capable of forming complexes with plurality of target ... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound having nrf2 activation effect.
Provided is a low-molec... |
|
|
Invention
|
Method for removing tert-butoxycarbonyl group.
Provided herein is a method for removing a tert-b... |
|
2022
|
Invention
|
Cxcr3 ligand having enhanced cxcr3-expressing cell migration activity.
The present disclosure re... |
|
|
Invention
|
Treatment of a demyelinating disease of the central nervous system (cns) with satralizumab.
The ... |
|
|
Invention
|
Drug formulation of anti-hla-dq2.5 antibody.
The present invention relates to anti-HLA-DQ2.5 ant... |
|
|
Invention
|
Method for preparing prefilled syringe formulation.
An object of the present invention is to red... |
|
|
Invention
|
Compound having photocleavable moiety, conjugate, and screening method using same.
The present i... |
|
|
Invention
|
Cytotoxicity-inducing therapeutic agent for use in treatment of cancer.
The present disclosure p... |
|
|
Invention
|
Uses of dll3-targeting multispecific antigen-binding molecules.
The disclosure provides uses of ... |
|
|
Invention
|
Method for producing arylamide derivative.
The present disclosure provides, for example, a metho... |
|
|
Invention
|
Protease-mediated target specific cytokine delivery using fusion polypeptide.
The present invent... |
|
|
Invention
|
Method for predicting in vivo pharmacokinetics of molecule.
The present invention provides a met... |
|
|
Invention
|
Preparation containing cyclic peptide compound and method for producing same.
The present invent... |
|
2021
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Prefilled syringe formulation with needle with needle shield containing novel modified antibody. ... |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or ... |
|
|
G/S
|
Pharmaceutical research and development services and providing information about medical and scie... |
|
2020
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives, cells or genes tha... |
|
2019
|
G/S
|
Pharmaceutical research and development services and
providing information about medical and sci... |
|
|
G/S
|
Pharmaceuticals consisting of antibodies or its fragments or
its derivatives; cells or genes tha... |
|
2017
|
G/S
|
Providing educational classes, seminars, workshops, symposiums and conferences and training servi... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neuromyelitis optica spectrum disorder |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment of hemophilia A. |
|
|
G/S
|
[ Pharmaceutical oncology preparations ] Providing educational classes, seminars, workshops, symp... |
|
|
G/S
|
pharmaceutical preparations for the treatment of Hemophilia A |
|
2013
|
G/S
|
pharmaceutical preparation, namely, an anti-cancer drug |
|
2012
|
G/S
|
Injection devices for medical purposes. |
|
|
G/S
|
injection devices for medical purposes |
